|
Thu, 12/08/2022 - 16:43 |
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model |
Myriad |
|
Wed, 11/02/2022 - 22:36 |
New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries |
Myriad |
|
Tue, 01/04/2022 - 23:37 |
Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference |
Myriad |
|
Mon, 01/03/2022 - 22:45 |
Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service |
Myriad |
|
Wed, 12/15/2021 - 00:10 |
New Years Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight Mental Health Monitor Nationwide Survey |
Myriad |
|
Mon, 12/13/2021 - 23:06 |
Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer |
Myriad |
|
Mon, 11/22/2021 - 21:39 |
The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults |
Myriad |
|
Sun, 11/21/2021 - 20:56 |
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment |
Myriad |
|
Mon, 10/18/2021 - 05:32 |
Myriad Genetics Names Pamela Wong as Chief Legal Officer |
Myriad |
|
Mon, 08/02/2021 - 02:25 |
Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries |
Myriad |
|
Wed, 07/21/2021 - 01:52 |
Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities |
Myriad |
|
Thu, 07/01/2021 - 06:43 |
Myriad Genetics Completes Sale of Myriad RBM to IQVIAs Q2 Solutions |
Myriad |
|
Tue, 06/15/2021 - 23:01 |
Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics |
Myriad |
|
Fri, 06/04/2021 - 00:51 |
Myriad Genetics CEO Paul J. Diaz to Present at Goldman Sachs 2021 Virtual Global Healthcare Conference |
Myriad |
|
Mon, 05/31/2021 - 23:21 |
Myriad Genetics Completes the Sale of Myriad myPath Melanoma, LLC, Laboratory to Castle Biosciences |
Myriad |
|
Tue, 05/25/2021 - 11:34 |
Mintz Advises Myriad Genetics in Sale of Pharmaceutical Research Services Business, Myriad RBM, to Q2 Solutions |
Mintz |
|
Mon, 05/24/2021 - 00:53 |
Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions |
Myriad |
|
Wed, 05/19/2021 - 22:25 |
Myriad Genetics Appoints Melissa Gonzales to Lead Womens Health Business |
Myriad |
|
Wed, 05/19/2021 - 00:10 |
Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries |
Myriad |
|
Wed, 05/05/2021 - 00:47 |
Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care Conference |
Myriad |
|
Mon, 05/03/2021 - 00:38 |
Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial Outlook at 2021 Investor Day |
Myriad |
|
Sun, 05/02/2021 - 22:05 |
Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmunes Vectra Testing Business to Labcorp |
Myriad |
|
Mon, 04/26/2021 - 23:03 |
Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath Melanoma, LLC, Laboratory to Castle Biosciences |
Myriad |
|
Mon, 03/29/2021 - 03:32 |
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders |
Myriad |
|
Thu, 03/25/2021 - 13:13 |
Myriad Genetics Receives Additional Reimbursement for myChoice Diagnostic System in Japan |
Myriad |
